Introduction: Periodontitis patients are known to suffer from endotoxemia, which may be among the major risk factors for atherosclerosis. In health, lipopolysaccharide (LPS) is mainly carried with high density lipoprotein (HDL) particles. Shift of LPS toward lipoproteins with lower densities may result in less effective endotoxin scavenging. Our aim was to determine plasma LPS activity and lipoprotein-distribution before and after treatment in periodontitis patients. Patients and Methods: Very low and intermediate density (VLDL-IDL), low density (LDL), HDL 2 , HDL 3 , and lipoprotein-deficient plasma (LPDP) were isolated by sequential ultracentrifugation. Patients included 34 subjects aged 53.5 ± 8.3 years, before and 6 months after periodontal treatment. Results: The mean LPS distribution decreased among lipoprotein classes as follows: VLDL-IDL 41.3 ± 12.1%, LPDP 25.0 ± 7.0%, HDL 3 13.1 ± 5.2%, LDL 11.5 ± 3.7%, and HDL 2 9.2 ± 2.8%. Plasma and VLDL-IDL-associated LPS correlated positively, and LDL-and HDL-associated LPS negatively with clinical periodontal parameters and plasma cytokine concentrations. Mean plasma LPS activity increased after periodontal treatment from 44.0 ± 17.0 to 55.7 ± 24.2 EU/ml (P = 0.006). No significant changes were found in LPS lipoprotein distribution and lipoprotein compositions after the treatment. Conclusions: Endotoxemia increases with severity of periodontitis. In periodontitis, LPS associates preferentially with the pro-atherogenic VLDL-IDL fraction. Periodontal treatment has only minor effects on plasma LPS activity or distribution, which reflects persistence of the disease.
INTRODUCTION
Periodontitis is a bacterial infection in tooth-supporting tissues, which eventually leads to loss of teeth if left untreated. Host response to bacterial insult leads to chronic inflammation characterized by gingival bleeding, formation of deepened periodontal pockets, and destruction of periodontal ligaments and alveolar bone. Periodontitis is one of the most common chronic infec-tions in adults. According to the Health-2000 survey conducted in Finland, 64% of adults had deepened periodontal pockets and 21% severe periodontitis. 1 Furthermore, 88% of Finnish adults harbour one or more of the main periodontal pathogens in their saliva. 2 When periodontitis develops and progresses, the bacterial composition of the subgingival biofilm changes from the dominance of Gram-positive bacteria to a majority Gram-negative bacteria. Bacteria and their components may have direct access to circulation through bleeding periodontal pockets. As a consequence, periodontitis patients suffer from endotoxemia. [3] [4] [5] About 80-97% of lipopolysaccharide (LPS) is bound to lipoproteins in the circulation, 6, 7 and all main lipoprotein classes are involved. 8 In the serum of healthy donors, LPS preferentially binds to high-density lipoproteins (HDL), which promotes LPS neutralization. 8 In sepsis patients, however, the majority of LPS is bound to very low-density lipoproteins (VLDL). 9 Binding of LPS to VLDL increases the hepatic uptake of the lipoprotein 3-fold, which in sepsis patients protects against LPSinduced toxicity. 10 LPS complexed with low-density lipoprotein (LDL) or VLDL is also taken up by macrophages in a process which gives rise to foam cell formation and progression of atherosclerosis. 11, 12 LPS activity in the circulation is determined by the levels of its carrier proteins, i.e. all lipoprotein classes, as well as lipopolysaccharide binding protein (LBP), CD14, and phospholipid transfer protein (PLTP). 13 Nevertheless, little is known of the long-term effects of endotoxemia associated with periodontitis.
Clinical periodontitis has been reported to be associated with an increased risk for cardiovascular diseases or atherosclerosis, 14, 15 but contrary studies have also been published. 16 Several studies imply that periodontal pathogens play an assisting role in atherogenesis: the number of periopathogenic species, 17 periodontal pathogen burden, 18 and seropositivity to the pathogens 19 increase the risk for atherosclerosis in humans, and administration of Porphyromonas gingivalis or Aggregatibacter actinomycetemcomitans induce early atherosclerotic alterations in animals. [20] [21] [22] [23] Since endotoxemia is an independent risk factor for cardiovascular disease, 24 it is justified to hypothesize that LPS contributes to periodontitis-induced atherosclerosis.
The aim of this study was to determine plasma LPS activity and lipoprotein distribution in periodontitis patients before and after periodontal treatment. Also, the mass compositions of lipoprotein subclasses were determined.
PATIENTS AND METHODS

Patients and periodontal treatment
Thirty-four patients with periodontitis were included in the study. Their mean age was 53.3 ± 8.1 years and body mass index 26.4 ± 3.4 kg/m 2 . From the patients, 19 were males and 15 females. Twenty patients did not smoke, 3 were former smokers, and 11 current smokers. All of the smokers had been smoking for 10 years or more.
All patients had a minimum of seven sites exhibiting at least 6 mm loss of clinical attachment. All had been referred to a specialist clinic in periodontology due to their severe periodontitis and were undergoing treatment for the condition. All the patients had periodontitis gravis et complicata 25 in which there is a horizontal loss of supporting tissue by one-third or more of the rootlength with bleeding on probing, furcation involvements of the multirooted teeth and/or angular bony defects with pus. Patients were excluded from the study if they had a known history of cardiovascular disease, on-going infection, or any other chronic medical diagnosis. Cardiovascular health was assessed on the basis of medical history, and those with a no history of cardiovascular disease were considered healthy in this regard.
Clinical examination for periodontal disease
Patients underwent a comprehensive periodontal examination including radiographs, and the oral health status was verified by a thorough clinical examination. A total of four dentists, all with extensive clinical experience in the field of periodontology undertook all clinical examinations. Teeth, gums and the oral mucosa were evaluated, and the pocket depth was measured using a calibrated (in mm) periodontal probe. Probing depth is the distance between the gingival margin and the bottom of the gingival pocket measured from six angles of each tooth. The presence or absence of dental plaque at the gingival margin along the mesial, buccal, distal and lingual aspects was determined. 26 The dental plaque was made visible by gently moving the tip of the probe along the gingival margin of the four sides of each tooth. Gingival pockets 4 mm or deeper were considered to be pathogenic. Gingival inflammation was noted as bleeding on probing and data are expressed as the proportion of bleeding sites from the total number of sites in the dentition.
Clinical treatment of periodontal disease
Patients underwent a thorough periodontal treatment, including extraction of teeth due to periodontitis, caries lesions, endodontic or other reasons. Thereafter, oral hygiene instructions were given, and scaling and root planing was done. This treatment continued until the patient obtained good oral hygiene by him/herself and was free from calculus. After 3 months, the patient was re-examined according to the baseline examination criteria. Those, who still had pockets deeper than 6 mm at the re-evaluation, had standardized periodontal flap surgery. According to normal periodontal treatment, a second healing process then took place for an additional 3 months. The patient was again re-examined and evaluated. The oral health status including radiographs was verified by a thorough clinical examination. The investigator who did the base-line examination also did the re-examinations and re-evaluations.
This study was approved by the Regional Ethics Committee of the Karolinska Institutet and was conducted in accordance with the Helsinki Declaration. All participants gave their informed consent. Analyses of all blood samples were performed blindly.
Plasma determinations
Fasting blood was collected into EDTA Vacutainer tubes. Plasma was obtained after centrifugation at 1500 g for 10 min and stored at -70°C until analysis. Samples were taken at base-line and after periodontal treatment on average 6 months after entering the study. Plasma total cholesterol, triglyceride, LDL, and HDL cholesterol concentrations as well as apoA-I were determined using standard clinical chemistry procedures with a Hitachi 917 analyzer (Roche AG Diagnostics, Mannheim, Germany). Serum C-reactive protein (CRP) levels were determined using a high-sensitivity commercial assay kit (DADE Behring, Deerfield, IL, USA). Serum interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α (R&D Systems Europe Ltd, Abingdon, UK) concentrations were determined according to the manufacturers' recommended protocols. LPS activity of plasma samples and lipoprotein fractions was determined by Limulus amebocyte lysate assay coupled with a chromogenic substrate (HyCult Biotechnology b.v., Uden, The Netherlands) on diluted (1:5, v/v in endotoxin-free water) samples.
Isolation of lipoproteins
Very low-density plus intermediate-density lipoproteins (IDL), LDL, HDL 2 , HDL 3 , and lipoprotein-deficient plasma (LPDP) were isolated by sequential ultracentrifugation 27 using a Beckman Airfuge at 160,000 g at +4°C. The run time was 2 h for VLDL-IDL, LDL, and HDL 2 , and 2.5 h for HDL 3 . KBr was used to adjust the density of the samples: VLDL-IDL 1.006-1.019 g/ml, LDL 1.019-1.063 g/ml, HDL 2 1.063-1.12 g/ml, HDL 3 1.12-1.21 g/ml and LPDP > 1.21 g/ml. HDL 3 and LPDP fractions were extensively dialyzed against TBS (10 mM Tris-HCl, pH 7.3, containing 150 mM NaCl) before determinations. Cholesterol, triglyceride and phospholipid concentrations on lipoprotein fractions were determined by routine enzymatic methods and LPS activity as described above.
Statistical analysis
Wilcoxon signed ranks test and Mann-Whitney U-test were used to test the significance of the differences between pre-and post-treatment samples, and between the genders or smokers and non-smokers, respectively. Interaction between parameters determined was done using Spearman's rank correlation. All analyses were performed with SPSS v.12.0.
RESULTS
The clinical periodontal parameters of the patients before and after periodontal treatment are summarized in Table 1 . According to all parameters registered, periodontal treatment was successful. The plasma parameters before and after periodontal treatment are presented in Table 2 . Concerning lipoprotein metabolism, there was a significant increase in HDL cholesterol, apoA-I, and triglyceride concentration, but no significant change in total or LDL cholesterol concentration. In addition, no significant changes were observed in the inflammatory markers, CRP, IL-1β, TNF-α, or IL-6, after periodontal treatment.
There was a modest, but statistically significant, increase in plasma LPS activity after the treatment ( .71 pg/ml; P = 0.011) than the 12 subjects whose LPS levels increased, respectively. The LPS distribution among the main lipoprotein classes was determined after their isolation by ultracentrifugation ( Fig. 1A) . The mean recovery percentage of LPS activity in the samples was 86% (range, 59-121%). The activity of LPS among the lipoproteins followed the descending order: VLDL-IDL 41.3 ± 12.1%, LPDP 25.0 ± 7.0%, HDL 3 13.1 ± 5.2%, LDL 11.5 ± 3.7%, and HDL 2 9.2 ± 2.8%. No significant differences were observed in the LPS distribution after periodontal treatment. In those 22 patients, whose LPS activity decreased after the treatment, a minor non-significant decrease was seen in all lipoprotein fractions (Fig. 1B) .
The mass compositions of the isolated lipoprotein classes were determined before and after periodontal treatment (Table 3 ). There were, however, no notable changes in the mean values between the time points, except a minor decrease in the VLDL-IDL phospholipid content. The VLDL-IDL fraction was highly enriched with cholesterol (40.9 ± 5.8%) at the cost of triglycerides (16.0 ± 5.1%). The cholesterol content of LDL was relatively low.
To determine how the variables were related, a correlation analyses was performed ( Table 4 ). Plasma LPS activity correlated positively with some clinical periodontal parameters, CRP, and triglyceride concentration, and negatively with HDL cholesterol and apoA-I concentrations. Similar correlation coefficients were obtained for VLDL-bound LPS activity, which, however, did not correlate with HDL. The correlations between clinical parameters and LDL or HDL bound LPS activities were inverse.
DISCUSSION
The main finding of the present study was that, in periodontitis, LPS is associated with the pro-atherogenic VLDL-IDL fraction, which was surprisingly highly enriched with cholesterol. Although the periodontal treatment was clinically successful, it did not cause 250 Kallio, Buhlin, Jauhiainen et al. notable changes in either plasma LPS activity or its distribution among lipoprotein classes. Plasma or VLDL-IDL bound LPS had a positive correlation with severity of periodontitis, CRP, and plasma triglyceride concentration, and a negative correlation with plasma HDL cholesterol concentration.
In contrast to our earlier study, 5 the mean LPS activity increased in the present group of periodontitis patients after periodontal treatment. Although the increment was not striking, the difference reached statistical significance. The increase in the mean LPS activity was due to 12 patients, since in 22 patients the LPS activity actually decreased significantly. Those 22 patients may have had a better 'systemic inflammation status' than those whose LPS activity increased. This was reflected by higher HDL cholesterol and lower CRP and IL-6 concentrations at base-line. Clear conclusions cannot, however, be drawn, since studying the inflammation parameters was not the main aim of the study and the number of patients would be too small for analysis.
Compared to published plasma LPS values, the present LPS activities were rather low (44 EU/ml), situated between those found in the healthy elderly with a mean of 6.7 EU/ml, 28 a random sample of the middle-aged with a mean of 25.4 EU/ml, 24 and middle-aged subjects including cardiovascular disease patients having a median of 122.8 EU/ml. 29 It is, however, difficult to compare results between different laboratories and populations due to the variety of assay kits available and to the low inter-assay reproducibility of the assays. 30 Highdensity lipoprotein cholesterol concentration increased after treatment in the present population, but was not sufficient to compensate for the increase seen in LPS activity: also, the LPS/HDL ratio increased significantly after periodontal treatment. As with LPS levels in the total population, the inflammation-associated markers such as CRP, IL-1β, TNF-α, and IL-6, did not decrease after periodontal treatment. The results suggest that, despite the successful clinical healing of the patients, their systemic inflammation status did not respond to the mechanical treatment applied, thereby reflecting the persistent nature of the disease. Unfortunately, we did not have bacterial samples from the patients, since base-line and follow-up microbiology might have shed light on the healing process.
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We found that 25% of the LPS activity existed free in plasma, which is in accordance with earlier results that around 80% of plasma total LPS is carried by the lipoprotein particles. 7 On average, 41% of the plasma LPS activity was bound to the VLDL-IDL fraction and other lipoprotein classes bound only 34% of the activity. There were no significant differences in LPS activities between LDL, HDL 2 and HDL 3 fractions. The distribution was, therefore, very similar to that found in patients with sepsis, although their LPS is more evenly distributed among VLDL and HDL subpopulations despite the sharp decrease in HDL cholesterol concentrations in acute phase response (APR). 9, 31 The VLDL-LPS complexes are readily taken up by the liver thereby protecting sepsis patients from the deleterious effects of LPS. 10 Very low-density lipoprotein strongly supports LPSinduced production of cytokines, 32 which in turn suppress the RNA expression level of VLDL receptors. 33 Although the following short-term hypertriglyceridemia is considered beneficial for the sepsis patients, it is an independent risk factor for atherosclerosis. 34, 35 The VLDL-IDL fractions characterized before and after periodontal treatment were highly enriched with cholesterol (41%), phospholipids (29%), and proteins (14%), and depleted in triglycerides (16%). The pattern suggests that a major proportion of the VLDL-IDL fraction was composed of IDL-class particles. These compositional data for VLDL are quite different to those reported for the 'normal' VLDL composition (27%, 12%, 8%, and 50%, respectively). 36 The VLDL composition during a chronic infection, like periodontitis, has not been studied earlier, and also APR-VLDL has gained only scarce attention in the literature. Kitchens and Thompson, 31 however, have presented preliminary data that these lipoproteins may contain higher than normal proportions of cholesterol. Their data suggest that these lipoproteins can replace HDL as the dominant LPS acceptor during sepsis, when HDL levels are low. 31 In the present study, the HDL cholesterol levels were also quite low: 80% of the subjects had HDL cholesterol lower than 1.5 mmol/l and 18% lower than 1.0 mmol/l. In addition, VLDL-LPS had a strong negative correlation with HDL 2 -LPS and HDL 3 -LPS (r = -0.601 and -0.754, respectively; P < 0.001).
Our study raises several interesting questions. The most important is the fate of LPS-VLDL. According to some in vitro studies, by binding to VLDL, LPS promotes the uptake of the particles by macrophages 37 thereby increasing their pro-atherogenic potency. The particle size, however, has been observed to be crucial for the uptake in vivo. In hypercholesterolemic rabbits, the cutoff limit for arterial wall uptake of lipoproteins was 75 nm. 38 Since the VLDL particle size generally ranges approximately between 30-80 nm, the largest particles may escape entering the intima. The limitation of our study is that we did not have an opportunity to determine the VLDL-IDL particle sizes. The composition, however, suggests that they represent a small-sized VLDL subpopulation. Another question is whether LPS remains associated with apoB-particles during their lipolytic processing up to the LDL stage. To our knowledge, there is no information on the lipase activity in post-heparin plasma of periodontitis patients. During APR, however, both lipoprotein and hepatic lipase activity decreases. 39 A high serum LPS activity is found to be an independent risk factor for atherosclerosis. 24, 40 In our earlier study, a high serum LPS activity predicted incident cardiovascular disease events, when it was associated with a low HDL cholesterol concentration or high CRP or IL-6. 29 Periodontitis patients have been observed to suffer from endotoxemia, [3] [4] [5] but without specific techniques to determine LPS concentrations derived from periodontal pathogens, definite conclusions cannot be drawn. Induction of systemic inflammation by LPS has been proposed to be the pathogenic mechanism behind the association of infections and atherosclerosis. Therefore, as suggested by our results, LPS may play a part in periodontitis-induced atherosclerosis as well.
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